Trial Details
RECRUITINGBasic Information
| Clinical ID | c502 |
|---|---|
| Identifier | NCT06520397 |
| Trial Title | Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Ustekinumab and Upadacitinib|DRUG: Ustekinumab |
Participant Information
| Sponsor | Sixth Affiliated Hospital, Sun Yat-sen University |
|---|---|
| City | Guangdong |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2024-07-15 |
|---|---|
| Primary Completion Date | 2026-12-31 |
| Completion Date | 2027-07-31 |